Microginin 764
| Internal ID | bff4fe42-8d7f-43d8-b57b-47dc33d26876 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | 2-[[2-[[1-[3-hydroxy-2-[[2-hydroxy-3-(methylamino)decanoyl]amino]butanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-indol-2-yl)propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C40H56N6O9/c1-4-5-6-7-8-14-30(41-3)35(49)38(52)45-34(24(2)47)39(53)46-20-11-15-33(46)37(51)43-31(21-25-16-18-28(48)19-17-25)36(50)44-32(40(54)55)23-27-22-26-12-9-10-13-29(26)42-27/h9-10,12-13,16-19,22,24,30-35,41-42,47-49H,4-8,11,14-15,20-21,23H2,1-3H3,(H,43,51)(H,44,50)(H,45,52)(H,54,55) |
| InChI Key | HQZPMNNNCIUMAW-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C40H56N6O9 |
| Molecular Weight | 764.90 g/mol |
| Exact Mass | 764.41087739 g/mol |
| Topological Polar Surface Area (TPSA) | 233.00 Ų |
| XlogP | 1.60 |
| Atomic LogP (AlogP) | 1.88 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 21 |
| 2-[[2-[[1-[3-hydroxy-2-[[2-hydroxy-3-(methylamino)decanoyl]amino]butanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-indol-2-yl)propanoic acid |
| 2-((2-(((1-(2-((1,2-dihydroxy-3-(methylamino)decylidene)amino)-3-hydroxybutanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino)-3-(1H-indol-2-yl)propanoate |
| 2-((2-((1-(3-hydroxy-2-((2-hydroxy-3-(methylamino)decanoyl)amino)butanoyl)pyrrolidine-2-carbonyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-(1H-indol-2-yl)propanoic acid |
| 2-{[2-({[1-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-hydroxybutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(1H-indol-2-yl)propanoate |
| RefChem:158632 |
| CHEBI:214802 |
| DTXSID901335259 |
| N-[2-Hydroxy-3-(methylamino)decanoyl]threonylprolyltyrosyl-3-(1H-indol-2-yl)alanine |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6417 | 64.17% |
| Caco-2 | - | 0.8915 | 89.15% |
| Blood Brain Barrier | - | 0.9250 | 92.50% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.4276 | 42.76% |
| OATP2B1 inhibitior | + | 0.5573 | 55.73% |
| OATP1B1 inhibitior | + | 0.8230 | 82.30% |
| OATP1B3 inhibitior | + | 0.8967 | 89.67% |
| MATE1 inhibitior | - | 0.9209 | 92.09% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9248 | 92.48% |
| P-glycoprotein inhibitior | + | 0.7387 | 73.87% |
| P-glycoprotein substrate | + | 0.8149 | 81.49% |
| CYP3A4 substrate | + | 0.7314 | 73.14% |
| CYP2C9 substrate | - | 0.5942 | 59.42% |
| CYP2D6 substrate | - | 0.7373 | 73.73% |
| CYP3A4 inhibition | - | 0.6107 | 61.07% |
| CYP2C9 inhibition | - | 0.7415 | 74.15% |
| CYP2C19 inhibition | - | 0.8023 | 80.23% |
| CYP2D6 inhibition | - | 0.8643 | 86.43% |
| CYP1A2 inhibition | - | 0.8618 | 86.18% |
| CYP2C8 inhibition | + | 0.7455 | 74.55% |
| CYP inhibitory promiscuity | - | 0.6935 | 69.35% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.6392 | 63.92% |
| Eye corrosion | - | 0.9905 | 99.05% |
| Eye irritation | - | 0.9172 | 91.72% |
| Skin irritation | - | 0.7911 | 79.11% |
| Skin corrosion | - | 0.9398 | 93.98% |
| Ames mutagenesis | - | 0.8300 | 83.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.5000 | 50.00% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | + | 0.5104 | 51.04% |
| skin sensitisation | - | 0.8998 | 89.98% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.9778 | 97.78% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.6847 | 68.47% |
| Acute Oral Toxicity (c) | III | 0.6554 | 65.54% |
| Estrogen receptor binding | + | 0.8509 | 85.09% |
| Androgen receptor binding | + | 0.7435 | 74.35% |
| Thyroid receptor binding | + | 0.5520 | 55.20% |
| Glucocorticoid receptor binding | + | 0.6061 | 60.61% |
| Aromatase binding | + | 0.5197 | 51.97% |
| PPAR gamma | + | 0.7473 | 74.73% |
| Honey bee toxicity | - | 0.8082 | 80.82% |
| Biodegradation | - | 0.7750 | 77.50% |
| Crustacea aquatic toxicity | + | 0.5800 | 58.00% |
| Fish aquatic toxicity | + | 0.9668 | 96.68% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.96% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.65% | 96.61% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.65% | 89.63% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.05% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.87% | 96.09% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 97.56% | 91.81% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.10% | 93.56% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 96.88% | 95.17% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.61% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.58% | 99.17% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.39% | 93.10% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 95.58% | 97.64% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 95.00% | 98.24% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 94.66% | 90.20% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 94.12% | 96.67% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.81% | 94.45% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.70% | 100.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.91% | 90.71% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 91.38% | 97.23% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 91.35% | 100.00% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 91.28% | 91.71% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.22% | 97.09% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 91.06% | 92.08% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 90.71% | 97.79% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.57% | 95.56% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.01% | 91.11% |
| CHEMBL2535 | P11166 | Glucose transporter | 88.33% | 98.75% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 88.18% | 97.14% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 87.39% | 95.00% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 87.31% | 97.50% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 87.28% | 92.86% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.18% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 86.46% | 91.19% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 85.84% | 93.03% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 85.82% | 93.33% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 85.61% | 90.08% |
| CHEMBL4072 | P07858 | Cathepsin B | 85.49% | 93.67% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 85.18% | 95.52% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 85.11% | 82.69% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 84.95% | 90.17% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 84.72% | 93.99% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 84.51% | 82.38% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 83.88% | 99.18% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 83.82% | 95.89% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 83.70% | 88.56% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 83.69% | 97.50% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.43% | 93.00% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 82.20% | 97.25% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 80.72% | 83.14% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 80.49% | 95.38% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 80.49% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683920 |
| LOTUS | LTS0016382 |
| wikiData | Q104246193 |